# Parkman Healthcare Partners

Parkman Healthcare Partners is an Asset Manager based in Stamford, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Stamford, United States
- **Region:** North America
- **Address:** Greenwich, CT, United States
- **Assets under management:** Undisclosed
- **Website:** parkmanhp.com
- **LinkedIn:** https://www.linkedin.com/company/parkman-healthcare-partners-llc

## Regulatory record

- **CRD number:** 300701
- **SEC file number:** 801-114849
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/300701

## About

Parkman Healthcare Partners is an SEC-registered investment adviser in Stamford, CT, registered since 2019. The firm manages approximately $1.7 billion in assets. It has 12 employees and 8 investment advisers.

## Sectors

- Biotech
- Pharma
- Medical Devices & Diagnostics
- Life Science Research
- Healthcare Services

## Offices

- Palo Alto
- Boston
- Stamford
- New York
- Miami

## People

- Gregory Martinez — Managing Member & Chief Investment Officer
- Michael Elgort — Partner, Chief Operating Officer, Chief Financial Officer & Chief Compliance Officer
- Jeremy Chase — Partner
- Logan Unland — Partner
- Matthew Ostrup, M.D. — Partner

## Questions

### Who makes the final investment decision at Parkman Healthcare Partners?

Gregory Martinez is the Managing Member and Chief Investment Officer. The partnership structure includes five named partners — Martinez, Michael Elgort, Jeremy Chase, Logan Unland, and Matthew Ostrup — but the firm’s website does not specify whether decisions are made by Martinez alone or by an investment committee that includes the other partners.

### What is Parkman’s investment approach to small- and mid-cap healthcare?

Parkman describes its process as thematic growth investing combined with risk management and protection. The firm targets value inflection points as standards of care evolve, applying a fundamental research process across biotech, pharma, medical devices, diagnostics, life science research, and services. No portfolio company names are publicly disclosed.

### Does Parkman Healthcare Partners disclose its AUM or fund structures?

No. The firm does not publicly disclose assets under management, specific fund vehicles, or discrete deployment figures. Employee ownership is stated, but there is no mention of closed-end fund structures, open-ended vehicles, or separate managed accounts on the public website.

### What geographies does Parkman invest in?

The firm states it seeks out innovations globally, though its listed office footprint is entirely domestic US. Without disclosed portfolio companies, it is impossible to confirm whether deployed capital extends to ex-US healthcare companies or remains concentrated in US-based small- and mid-cap names.

## Related profiles

- [Ergotron](https://altss.com/profile/ergotron)
- [KreaMedica](https://altss.com/profile/kreamedica-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/parkman-healthcare-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology